Diamant Thaçi Selected Research

secukinumab

3/2024	Response Types and Factors Associated with Response Types to Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis from Two Randomized Clinical Trials.
1/2023	Bimekizumab efficacy and safety in patients with moderate to severe plaque psoriasis: Two-year interim results from the open-label extension of the randomized BE RADIANT phase 3b trial.
6/2022	Efficacy of guselkumab versus secukinumab in subpopulations of patients with moderate-to-severe plaque psoriasis: results from the ECLIPSE study.
5/2022	Drug survival of secukinumab, ustekinumab, and certolizumab pegol in psoriasis: a 2-year, monocentric, retrospective study.
4/2020	Secukinumab-induced chronic discoid lupus erythematosus.
12/2019	Secukinumab demonstrates sustained efficacy in clearing skin and improving patient-reported outcomes in patients with moderate-to-severe psoriasis through 2 years of treatment: Results from the CLEAR study.
1/2019	Impact of Secukinumab on Endothelial Dysfunction and Other Cardiovascular Disease Parameters in Psoriasis Patients over 52 Weeks.
1/2018	Effect of secukinumab on quality of life and psoriasis-related symptoms: A comparative analysis versus ustekinumab from the CLEAR 52-week study.
1/2017	Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study.
9/2015	Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Diamant Thaçi Research Topics

Disease

64	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2024 - 08/2003
37	Atopic Dermatitis (Atopic Eczema) 03/2024 - 01/2003
12	Infections 03/2024 - 07/2014
12	Psoriatic Arthritis 02/2024 - 01/2006
12	Pruritus (Itching) 07/2023 - 11/2004
11	Neoplasms (Cancer) 03/2024 - 10/2006
10	Eczema 12/2023 - 11/2004
8	Pain (Aches) 03/2024 - 11/2012
8	Skin Diseases (Skin Disease) 01/2023 - 08/2003
6	Inflammation (Inflammations) 03/2024 - 07/2014
5	Nasopharyngitis 01/2023 - 07/2014
4	Body Weight (Weight, Body) 11/2023 - 11/2012
3	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 01/2019
3	Acne Vulgaris 03/2024 - 01/2021
3	Rheumatoid Arthritis 02/2024 - 04/2022
3	Skin Neoplasms (Skin Cancer) 12/2023 - 01/2010
3	Asthma (Bronchial Asthma) 01/2021 - 07/2014
2	Herpes Zoster 03/2024 - 06/2019
2	Fatigue 02/2024 - 03/2013
2	Conjunctivitis 03/2023 - 05/2019
2	Carcinoma (Carcinomatosis) 01/2023 - 08/2010
2	Ulcerative Colitis 01/2023 - 11/2021
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2023 - 01/2021
2	Oral Candidiasis (Thrush) 01/2023 - 01/2022
2	Migraine Disorders (Migraine) 07/2022 - 02/2022
2	Bullous Pemphigoid (Pemphigoid) 01/2022 - 08/2021
2	Dermatitis 11/2021 - 01/2003
2	Headache (Headaches) 01/2021 - 07/2014
2	Melanoma (Melanoma, Malignant) 09/2015 - 10/2006
2	Drug-Related Side Effects and Adverse Reactions 03/2013 - 01/2006
1	Venous Thromboembolism 05/2024
1	Tachycardia (Tachyarrhythmias) 05/2024
1	Atrial Fibrillation 05/2024
1	Heart Diseases (Heart Disease) 05/2024
1	Heart Failure 05/2024
1	Cardiac Arrhythmias (Arrythmia) 05/2024
1	Atherosclerotic Plaque (Atheroma) 04/2024
1	Folliculitis (Sycosis) 03/2024
1	Axial Spondyloarthritis 02/2024

Drug/Important Bio-Agent (IBA)

23	dupilumabIBA 04/2024 - 07/2014
10	secukinumabIBA 03/2024 - 09/2015
10	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2023 - 06/2007
9	TYK2 Kinase (Tyrosine Kinase 2)IBA 03/2024 - 10/2018
9	deucravacitinibIBA 03/2024 - 10/2018
9	Adalimumab (Humira)FDA Link 03/2024 - 11/2012
8	apremilastIBA 03/2024 - 08/2017
8	Monoclonal AntibodiesIBA 10/2023 - 11/2012
7	InterleukinsIBA 04/2024 - 01/2016
7	Ustekinumab (CNTO 1275)FDA Link 11/2023 - 09/2015
7	calcipotriene (calcipotriol)FDA LinkGeneric 05/2021 - 01/2005
6	Janus Kinase InhibitorsIBA 03/2024 - 12/2016
5	Janus KinasesIBA 03/2024 - 01/2021
5	guselkumabIBA 03/2024 - 02/2022
5	Etanercept (Enbrel)FDA Link 02/2024 - 09/2015
5	tildrakizumabIBA 12/2023 - 01/2017
5	bimekizumabIBA 11/2023 - 01/2022
5	Immunoglobulin A (IgA)IBA 11/2023 - 01/2021
5	betamethasone-17,21-dipropionate (betamethasone dipropionate)FDA LinkGeneric 05/2021 - 01/2006
5	pimecrolimus (Elidel)FDA Link 01/2010 - 01/2003
4	upadacitinibIBA 03/2024 - 01/2020
4	Interleukin-17 (Interleukin 17)IBA 09/2023 - 01/2019
4	CytokinesIBA 01/2023 - 01/2003
4	Interleukin-13IBA 01/2021 - 07/2014
4	Calcineurin InhibitorsIBA 07/2014 - 06/2007
3	omega-Chloroacetophenone (Mace)IBA 05/2024 - 01/2023
3	GlucocorticoidsIBA 02/2024 - 07/2014
3	Prostaglandins AIBA 12/2023 - 01/2017
3	Interleukin-23 (Interleukin 23)IBA 09/2023 - 01/2017
3	abrocitinibIBA 07/2023 - 01/2021
3	ixekizumabIBA 02/2022 - 10/2018
3	Interleukin-4 (Interleukin 4)IBA 01/2021 - 07/2014
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2024 - 08/2018
2	spesolimabIBA 12/2023 - 10/2023
2	lebrikizumabIBA 07/2023 - 03/2023
2	Glucose (Dextrose)FDA LinkGeneric 07/2022 - 02/2022
2	Certolizumab Pegol FDA Link 05/2022 - 08/2018
2	Creatine Kinase (Creatine Phosphokinase)IBA 05/2022 - 01/2021
2	EnzymesIBA 05/2022 - 03/2013
2	risankizumabIBA 02/2022 - 01/2019
2	SteroidsIBA 01/2022 - 01/2003
2	tofacitinibIBA 11/2021 - 12/2016
2	Janus Kinase 1IBA 01/2021 - 01/2020
2	Vitamin D FDA LinkGeneric 12/2020 - 09/2017
2	EsapentIBA 09/2017 - 09/2015
2	Methotrexate (Mexate)FDA LinkGeneric 01/2017 - 03/2016
2	Alitretinoin FDA Link 12/2016 - 11/2016
2	FumaratesIBA 05/2013 - 02/2011
2	Leflunomide (Arava)FDA LinkGeneric 03/2013 - 01/2006
2	Tacrolimus (Prograf)FDA LinkGeneric 09/2009 - 01/2005
2	Ointments (Pastes)IBA 01/2006 - 01/2005
1	Interleukin-18 (Interleukin 18)IBA 04/2024
1	Interleukin-6 (Interleukin 6)IBA 04/2024
1	Tryptophan (L-Tryptophan)FDA Link 03/2024
1	baricitinibIBA 12/2023
1	Biosimilar PharmaceuticalsIBA 11/2023

Therapy/Procedure

24	Therapeutics 04/2024 - 08/2003
2	Biological Therapy 03/2024 - 01/2022
2	Skin Care 06/2023 - 08/2003
1	Precision Medicine 03/2024
1	Retreatment 12/2023